Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,259 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
As Fed policy shifts and market volatility persists, analysts say the era of an automatic market backstop is fading. ...
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
A single insider trade can spark headlines, but it isn’t a crystal ball. This guide explains how to read a director s...
Bitcoin recently touched a six-week low as volatility remained elevated. This piece explains why bitcoin traders incr...
A routine Facebook Marketplace jewelry sale can quickly spiral into a dangerous encounter. Learn how to spot warning ...
When markets pull back, investors ask a simple but serious question: should you buy the Invesco QQQ ETF during stock ...
Costco stock has flashed sell-side headlines and uncertain momentum. This guide breaks down what a dip means for COST...
History says you'll regret not buying Amazon stock if you wait for perfect timing. This guide breaks down the lessons...